Citigroup
KMTS

Citigroup’s Kestra Medical Technologies KMTS Stock Holding History

Citigroup’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Buy
13,687
+11,595
+554% +$243K ﹤0.01% 4069
2026
Q1 		$41.7K Sell
2,092
-632
-23% -$14.9K ﹤0.01% 4593
2025
Q4 		$72.2K Buy
2,724
+2,217
+437% +$57.1K ﹤0.01% 4449
2025
Q3 		$12K Sell
507
-4,132
-89% -$73.9K ﹤0.01% 4961
2025
Q2 		$76.9K Buy
4,639
+4,634
+92,680% +$101K ﹤0.01% 4546
2025
Q1 		$125 Buy
+5
New +$115 ﹤0.01% 5431

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Citigroup's KMTS Position: Q2 2026 in Review

Citigroup increased its Kestra Medical Technologies (KMTS) stake by 554% in Q2 2026, buying an estimated $243K and bringing the position to 13,687 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #4069.

Citigroup first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Citigroup held 13,687 shares of Kestra Medical Technologies worth $348K as of Q2 2026.
  • Citigroup bought 11,595 Kestra Medical Technologies shares in Q2 2026, an estimated $243K.
  • Kestra Medical Technologies made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4069 holding.
  • Citigroup first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.